Preimplantation Genetic Diagnosis (PGD) is a revolutionary genetic screening technique used alongside In Vitro Fertilization (IVF) to detect chromosomal abnormalities in embryos before implantation. This procedure is highly beneficial for couples at risk of passing genetic disorders to their children or those who have experienced repeated IVF failures and miscarriages.

The PGD process begins with ovarian stimulation, where fertility medications encourage the development of multiple eggs. These eggs are then retrieved and fertilized in a controlled laboratory setting, resulting in embryo formation. Once the embryos reach a specific stage of development, a small biopsy is performed to extract a few cells from each embryo for genetic testing.

The extracted cells undergo detailed genetic analysis to identify any chromosomal abnormalities or inherited conditions such as cystic fibrosis, Down syndrome, sickle cell anemia, and other genetic disorders. Only embryos that are free from abnormalities are considered viable for implantation. This process significantly reduces the risk of genetic diseases and increases the likelihood of a successful pregnancy.

PGD not only helps couples avoid passing genetic conditions to their children but also improves IVF success rates by selecting the healthiest embryos. For individuals experiencing repeated miscarriages or unsuccessful IVF cycles, PGD provides valuable insights into embryo quality, ensuring a higher chance of a successful pregnancy.

With Dr. Chaitali Taware’s expertise, patients receive personalized fertility care, state-of-the-art genetic testing, and compassionate support throughout their reproductive journey. PGD enhances reproductive success, providing families with the confidence of a healthy pregnancy.